Skip to content
WeighLab

Omzo vs MEDVidi

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Omzo

Provider comparison

Patients who want weight-loss care alongside other telehealth services and can confirm package duration before paying.

Semaglutide / month
$179Initial GLP-1 package; $299 follow-up package (supply duration unspecified)
Tirzepatide / month
$259Initial tirzepatide package; $399 follow-up package (supply duration unspecified)
Index 53/100 · Grade CChecked October 2026

MEDVidi

Provider comparison

Patients who want weight-loss care bundled with an existing mental-health telehealth relationship.

Semaglutide / month
Not disclosed
Tirzepatide / month
Not disclosed
Index 52/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Omzo has the higher Cost-Efficiency Index: 53/100 versus 52/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Omzo
U.S. residents only; confirm state eligibility
MEDVidi
35 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Omzo

MEDVidi

Semaglutide / month
Omzo: $179Initial GLP-1 package; $299 follow-up package (supply duration unspecified)
MEDVidi: Not disclosed
Tirzepatide / month
Omzo: $259Initial tirzepatide package; $399 follow-up package (supply duration unspecified)
MEDVidi: Not disclosed
Semaglutide / year (modeled)
Omzo: —
MEDVidi: —
Tirzepatide / year (modeled)
Omzo: —
MEDVidi: —
State availability
Omzo: U.S. residents only; confirm state eligibility
MEDVidi: 35 states
Oral / sublingual option listed
Omzo: Not listed
MEDVidi: Not listed
Brand-name access listed
Omzo: Yes
MEDVidi: Yes
Provider facts checked
Omzo: October 2026
MEDVidi: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Omzo

Patients who want weight-loss care alongside other telehealth services and can confirm package duration before paying.

Reasons to consider it

  • Terms publish initial and follow-up consultation-and-medication package amounts
  • Compounded packages include consultation, medication, shipping and support
  • Offers a separate brand-name prescription route

What to weigh up

  • Package duration is not specified, so the published totals do not establish monthly medication prices
  • Initial packages cost less than follow-up packages
  • The compounding pharmacy and medical director are not named

MEDVidi

Patients who want weight-loss care bundled with an existing mental-health telehealth relationship.

Reasons to consider it

  • Prescribes real branded GLP-1s (Wegovy, Zepbound) rather than only compounded alternatives
  • Transparent, flat consultation pricing ($195 initial, $159 follow-up, $249 bundled)
  • Broad multi-condition platform may suit patients with comorbid mental-health needs

What to weigh up

  • No medication pricing disclosed anywhere -- true monthly cost is unknowable before booking
  • Weight loss is a secondary service bolted onto a psychiatry-focused platform, not a core specialty
  • No named medical director or clinical leadership

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

OmzoMEDVidi
Normalized Cost/Month
Omzo:
45/100
MEDVidi:
45/100
Price Transparency
Omzo:
54/100
MEDVidi:
30/100
Nationwide Access
Omzo:
24/100
MEDVidi:
66/100
Formulation Options
Omzo:
79/100
MEDVidi:
53/100
Clinical Oversight
Omzo:
76/100
MEDVidi:
74/100
Contract Flexibility
Omzo:
55/100
MEDVidi:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.